Doxorubicin-conjugated RGD peptide nanoparticles, responsive to MMP-9 and pH, transformed from spheres to rods in the tumor environment, enhancing penetration and doxorubicin release and inducing apoptosis [138]. This evidence concerns the gene MMP9 and neoplasm.